262 related articles for article (PubMed ID: 10769104)
1. Glucocorticoid-induced osteoporosis: is the bone density decrease the only explanation?
Lespessailles E; Poupon S; Adriambelosoa N; Pothuaud L; Siroux V; Bouillon S; Benhamou CL
Joint Bone Spine; 2000; 67(2):119-26. PubMed ID: 10769104
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
Cortet B; Hachulla E; Barton I; Bonvoisin B; Roux C
Rev Rhum Engl Ed; 1999 Apr; 66(4):214-9. PubMed ID: 10339777
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
4. Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?
van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
Clin Exp Rheumatol; 2003; 21(2):155-60. PubMed ID: 12747268
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of glucocorticoid-induced osteoporosis with alfacalcidol/calcium and vitamin D/calcium].
Ringe JD; Cöster A; Meng T; Schacht E; Umbach R
Z Rheumatol; 2000 Jun; 59(3):176-82. PubMed ID: 10929446
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
[TBL] [Abstract][Full Text] [Related]
7. Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.
Saag KG; Wagman RB; Geusens P; Adachi JD; Messina OD; Emkey R; Chapurlat R; Wang A; Pannacciulli N; Lems WF
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):445-454. PubMed ID: 29631782
[TBL] [Abstract][Full Text] [Related]
8. The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.
Kaji H; Yamauchi M; Chihara K; Sugimoto T
Endocr J; 2006 Feb; 53(1):27-34. PubMed ID: 16543669
[TBL] [Abstract][Full Text] [Related]
9. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Buckley LM; Leib ES; Cartularo KS; Vacek PM; Cooper SM
Ann Intern Med; 1996 Dec; 125(12):961-8. PubMed ID: 8967706
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
[TBL] [Abstract][Full Text] [Related]
11. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
Ringe JD; Dorst A; Faber H; Schacht E; Rahlfs VW
Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
[TBL] [Abstract][Full Text] [Related]
12. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
[TBL] [Abstract][Full Text] [Related]
13. Verification of osteoporotic vertebral fractures caused by glucocorticoids.
Janković T; Svorcan JZ; Bosković K
Med Pregl; 2014; 67(3-4):118-22. PubMed ID: 24961055
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
Cortet B; Flipo RM; Blanckaert F; Duquesnoy B; Marchandise X; Delcambre B
Rev Rhum Engl Ed; 1997; 64(7-9):451-8. PubMed ID: 9338926
[TBL] [Abstract][Full Text] [Related]
15. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H
J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766
[TBL] [Abstract][Full Text] [Related]
16. Bone status in glucocorticoid-treated men and women.
Leib ES; Winzenrieth R
Osteoporos Int; 2016 Jan; 27(1):39-48. PubMed ID: 26252975
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced osteoporosis: a cross-sectional study.
Brandli DW; Golde G; Greenwald M; Silverman SL
Steroids; 1991 Oct; 56(10):518-23. PubMed ID: 1805453
[TBL] [Abstract][Full Text] [Related]
18. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides-Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort.
Palmowski A; Wiebe E; Muche B; Hermann S; Dejaco C; Matteson EL; Buttgereit F
Cells; 2022 Feb; 11(3):. PubMed ID: 35159345
[TBL] [Abstract][Full Text] [Related]
20. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Luengo M; Picado C; Del Rio L; Guañabens N; Montserrat JM; Setoain J
Thorax; 1991 Nov; 46(11):803-6. PubMed ID: 1771602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
